Papers

3

Total Citations

49

H-Index

3

About

Dr. Luai Tabaza is a pioneering interventional cardiologist whose research focuses on the application of robotic-assisted technologies in cardiovascular procedures, particularly during the COVID-19 pandemic. His major contributions demonstrate how robotic systems can enhance procedural precision, reduce operator radiation exposure, and minimize viral transmission risks. In his landmark 2020 case report (24 citations), Dr. Tabaza described the first use of robotic-assisted percutaneous coronary intervention in a COVID-19 patient, effectively reducing healthcare worker exposure while maintaining excellent clinical outcomes. He further advanced the field by successfully performing robotic-assisted carotid artery stenting with distal embolic protection in high-risk surgical patients (21 citations), showcasing the versatility of the CorPath GRX system beyond coronary interventions. Dr. Tabaza’s work has been especially timely, as he compellingly argued that the pandemic era demands greater adoption of robotics in catheterization laboratories to protect both patients and staff. His research has helped establish a new paradigm for performing urgent endovascular procedures with minimal physical contact, positioning him as a key voice in the future of teleoperated cardiovascular care.

Research Focus

Key Achievements

3
H-Index
3
Papers
49
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
<scp>Robotic‐assisted</scp> percutaneous coronary intervention in a <scp>COVID</scp>‐19 patient
24 citations · 2020
📈 Most Prolific Year: 2020 (3 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Einstein Healthcare Network, Einstein Medical Center Philadelphia

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago